Document Detail

Thrombotic thrombocytopenic purpura: early and late responders.
MedLine Citation:
PMID:  9034283     Owner:  NLM     Status:  MEDLINE    
Thrombotic thrombocytopenic purpura (TTP) is characterized by micro-angiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological symptoms, renal involvement, and fever. We describe our experience in 70 serially encountered TTP patients in the last decade who were treated with a standard therapeutic plasma exchange (TPE) protocol. Seventy percent of the patients were females. The median age of the patients was 43 years (range: 8-80). Sixty patients (85.7%) had a complete response to TPE therapy. This represented 91% of 66 who received at least one TPE. Ten patients died, two patients died before and two during the first plasma exchange. The median number of TPEs performed was nine (range: 1-85). Thirty-five (58%) out of 60 responded to 3-9 TPEs, and 25 (42%) required 10-34 TPEs for the response. The median total plasma volume exchanged was 28 liters (range: 2.7-250 L) and the mean plasma volumes exchanged during each procedure was 3.2 (SD +/- 1.09 L). The patients were classified into early responders (ER) and late responders (LR). ERs had a mean platelet count of 180 x 10(9)/L by Day 5, mean LDH of 643 IU/L by Day 7, and required median of seven TPEs. LRs had a mean platelet count of 122 x 10(9)/L by Day 5, mean LDH of 885 IU/L by Day 7, and required median of 19 TPEs (P = 0.001). The platelet counts were significantly higher (P = 0.01-0.03) in ERs on Days 1, 3, and 5 as compared to LRs but the LDH did not differ significantly. Seventy-seven percent of LRs had exacerbation of TTP and 18% had relapse as compared to 7% each in ERs. Thirteen patients were in coma/semicoma at presentation. Out of these, six died, making coma a bad prognostic indicator. Five of the seven survivors in coma had received two single-plasma volume exchanges on Day 1. In conclusion, 91% of TTP patients had an excellent response to plasma exchange therapy with FFR Coma/ semicoma appears to be a bad prognostic indicator. LRs needed prolonged treatment with a greater number of patients experiencing exacerbation and relapse of TTP as compared to ERs.
R Sarode; J L Gottschall; R H Aster; J G McFarland
Related Documents :
11754423 - Hemoglobin s-c disease revisited: clinical study of 106 adults.
12181063 - Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure ...
19406543 - Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syn...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of hematology     Volume:  54     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-03-18     Completed Date:  1997-03-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  102-7     Citation Subset:  IM    
The Blood Center of Southeastern Wisconsin, Inc., Milwaukee 53201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Blood Transfusion / adverse effects
Coma / etiology
Hypersensitivity / etiology
Middle Aged
Plasma Exchange* / adverse effects
Purpura, Thrombotic Thrombocytopenic / mortality,  therapy*
Retrospective Studies
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Platelet microparticles and calcium homeostasis in acute coronary ischemias.
Next Document:  Laboratory diagnosis of anemia and related diseases using multivariate analysis.